{"favorite_id": 357, "calc_type": "", "dosing": false, "full_title_en": "ABCD\u00b2 Score for TIA", "short_title_en": "ABCD\u00b2 Score", "medium_description_en": "Estimates the risk of stroke after a suspected transient ischemic attack (TIA).", "short_description_en": "Stroke risk after TIA: inpt vs outpt.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Stroke/TIA"], "specialty_en": ["Critical Care", "Emergency Medicine", "Family Practice", "Hospitalist Medicine", "Internal Medicine", "Neurology", "Primary Care"], "chief_complaint_en": ["Weakness"], "system_en": ["Neurologic"], "search_abbreviation_en": ["stroke", "neuro", "cva", "tia", "abcd2", "stroke risk"], "slug": "abcd2-score-tia", "seo": {"meta_description_en": "The ABCD2 Score for TIA estimates risk of stroke (CVA) after a transient ischemic attack (TIA), according to patient risk factors.", "keywords_en": "abcd2 score, abcd2 calc, stroke calc, stroke score, TIA score, TIA stroke risk, TIA risk, ABCD2, TIA risk stroke, TIA calc, abcd2 risk, CVA from TIA, abcd2 TIA, abcd2, abcd calc, abcd tia, abcd stroke, abcd tia calc, abcd tia score, tia risk, tia risk score, tia risk calc, mini stroke risk, mini stroke calc, minor stroke risk, minor stroke calc, abcd blood pressure, abcd2 blood pressure, abcd2 bp, abcd bp, abcd2 dm, abcd dm, abcd diabetes, abcd2 diabetes."}, "content": {"how_to_use": {"use_case_en": "<p>The ABCD<sup>2</sup> score can help physicians risk stratify stroke in patients presenting with a TIA.</p>", "pearls_pitfalls_en": "<p>The ABCD<sup>2</sup> score was developed to help physicians risk stratify patients presenting with a TIA for how likely they are to suffer a subsequent stroke.</p> <ul> <li>The largest prospective study of using the ABCD<sup>2</sup> score in the emergency department found that the score performed poorly (low sensitivity for identifying low risk patients, low specificity for identifying high risk patients).</li> <li>Multiple studies have shown that as the ABCD<sup>2</sup> score increases the risk of a subsequent stroke also increases.</li> <li>Patients with a low baseline risk of stroke (\u2264 2%) with a low ABCD<sup>2</sup> score (0-2) are at low risk for having a stroke within the next 7 days (0.4-0.8%).</li> </ul> <p><strong>Points to keep in mind:</strong></p> <ul> <li>The ABCD<sup>2</sup> score was developed in the outpatient (non-emergency department) setting.</li> <li>It has been shown to have lower accuracy when used by non-specialists (primary care or emergency physicians).</li> <li>The ABCD<sup>2</sup> has less impact on risk stratification when applied in settings where the patients were at low baseline risk of stroke.</li> </ul>", "why_use_en": "<p>There are approximately 250,000 transient ischemic attacks (TIAs) diagnosed in the United States annually.</p> <p>The ABCD<sup>2</sup> score may help physicians identify those patients with TIA who are at very low risk of stroke and may be appropriate for an outpatient work-up vs. those who are at increased risk and may benefit from hospital admission.</p> "}, "next_steps": {"advice_en": "", "management_en": "<p>Consider further imaging modalities including MRI and carotid ultrasound.</p> <p>Consider consulting Neurology to help determine whether the patient would benefit from further inpatient evaluation or to expedite outpatient follow-up when appropriate.</p> <p>In patients who are determined at high risk for developing a stroke:</p> <ul> <li>Consult Neurology.</li> <li>Consider obtaining an MRI and other appropriate vascular and embolic imaging.</li> <li>Have a lower threshold to admit to the patient for further evaluation.</li> </ul> <p>In patients who are determined to be at low risk of developing a stroke in the short term:</p> <ul> <li>Arrange expedited evaluation as an outpatient with the goal of obtaining the relevant studies and consultations within 24 hours.</li> </ul>", "critical_actions_en": "<ul> <li>The ABCD<sup>2</sup> score should not be used as a substitute for clinical judgement or decision making.</li> <li>In populations with a low baseline stroke risk, a low ABCD<sup>2</sup> score (0-2) correlates with a less than 1% risk of stroke within the next week. These patients may be appropriate for expedited outpatient evaluation.</li> <li>In centers where computed tomography and carotid ultrasound studies are performed in collaboration with a stroke service, adding the ABCD<sup>2</sup> score to the evaluation appears unnecessary.</li> </ul> "}, "about": {"formula_en": "<p>Addition of the selected points.</p>", "more_info_en": "<p>See formula table, below:</p>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered table-hover\">\n<tbody>\n<tr>\n<th>Criteria</th>\n<th>Value</th>\n<th>Points</th>\n</tr>\n<tr>\n<td>Age &ge; 60 years</td>\n<td>Y/N</td>\n<td>+1</td>\n</tr>\n<tr>\n<td>BP &ge; 140/90 mmHg</td>\n<td>Y/N</td>\n<td>+1</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Clinical features of the TIA</td>\n<td>Unilateral Weakness</td>\n<td>+2</td>\n</tr>\n<tr>\n<td>Speech disturbance without weakness</td>\n<td>+1</td>\n</tr>\n<tr>\n<td>Other symptoms</td>\n<td>0</td>\n</tr>\n<tr>\n<td rowspan=\"3\">Duration of symptoms</td>\n<td>&lt; 10 minutes</td>\n<td>0</td>\n</tr>\n<tr>\n<td>10-59 minutes</td>\n<td>+1</td>\n</tr>\n<tr>\n<td>&ge; 60 minutes</td>\n<td>+2</td>\n</tr>\n<tr>\n<td>History of diabetes</td>\n<td>Y/N</td>\n<td>+1</td>\n</tr>\n</tbody>\n</table>\n</div>", "evidence_based_medicine_en": "<ul> <li>In one study of 713 patients reviewed by an expert neurologist, 642 (90%) were judged to likely have experienced a true TIA. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/18688003' target='_blank'>Josephson 2008</a>) <ul> <li>Ninety-day stroke risk was 24% (95% CI, 20% to 27%) in the group judged to have experienced a true TIA and 1.4% (0% to 7.6%) in the group judged to not have a true TIA (P&lt;0.0001). (<a href='http://www.ncbi.nlm.nih.gov/pubmed/18688003' target='_blank'>Josephson 2008</a>)</li> <li>ABCD<sup>2</sup> scores were higher in those judged to have a true TIA compared with others (P=0.0001). In the group judged to have a true TIA, 90-day stroke risk increased as ABCD<sup>2</sup> score increased (P&lt;0.0001). (<a href='http://www.ncbi.nlm.nih.gov/pubmed/18688003' target='_blank'>Josephson 2008</a>)</li> </ul> </li> <li>In its derivation study, the ABCD<sup>2</sup> score classified 21% of patients as high risk (score 6-7, 8.1% 2-day stroke risk), 45% as moderate risk (score 4-5, 4.1% 2-day stroke risk), and 34% as low risk (score 0-3, 1.0% 2-day stroke risk). (<a href='http://www.ncbi.nlm.nih.gov/pubmed/17258668' target='_blank'>Johnston 2007</a>)</li> <li>The largest ED-based study was a prospective cohort study of 2,056 subjects and found that the ABCD<sup>2</sup> score performed poorly in the acute setting. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/21646462' target='_blank'>Perry 2011</a>) <ul> <li>In high risk patients (score &gt;5) the ABCD<sup>2</sup> score was only 31.6% sensitive identifying patients who suffered a stroke within 7 days. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/21646462' target='_blank'>Perry 2011</a>)</li> <li>Using the low risk cut-off recommended by AHA (score &gt;2) the ABCD<sup>2</sup> score had a specificity of only 12.5% for stroke within 7 days. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/21646462' target='_blank'>Perry 2011</a>)</li> <li>This study found the the ABCD<sup>2</sup> score was incorrectly calculated in the ED in 1/3 of patients. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/21646462' target='_blank'>Perry 2011</a>)</li> </ul> </li> <li>A meta-analysis of 33 studies including 16,070 subjects found that the ABCD<sup>2</sup> score performed poorly in patients with high baseline stroke risk, and was only marginally better when applied to low risk patients. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/22700810' target='_blank'>Sanders 2012</a>) <ul> <li>Positive likelihood ratios ranged from 1-2. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/22700810' target='_blank'>Sanders 2012</a>)</li> <li>Negative likelihood ratios ranged from 0.4-1. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/22700810' target='_blank'>Sanders 2012</a>)</li> <li>The authors conclude that the ABCD<sup>2</sup> score would require further evaluation and validation before \u201cconfidently recommending the tool in guidelines.\u201d (<a href='http://www.ncbi.nlm.nih.gov/pubmed/22700810' target='_blank'>Sanders 2012</a>)</li> </ul> </li> <li>A review of this meta-analysis noted that the majority of the included studies were retrospective and that only 8 of the 33 included patients presenting to the ED (this subgroup was not separately analysed). (<a href='http://www.ncbi.nlm.nih.gov/pubmed/23842051' target='_blank'>Lee 2013</a>)</li> <li>The authors note that the poor performance of the ABCD<sup>2</sup> score in the ED setting, combined with difficulties in arranging the necessary imaging and specialty follow-up within the AHA recommended 24-hour window, that most ED physicians were likely to choose to perform a rapid evaluation of TIA patients (imaging, possible neurology consultation) regardless of the ABCD2 score. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/23842051' target='_blank'>Lee 2013</a>)</li> <li>A prospective observational study of 637 patients presenting to the ED found that the ABCD<sup>2</sup> score did not add incremental value beyond an ED evaluation that included central nervous system and carotid artery imaging in the ability to risk-stratify patients with transient ischemic attack in the study's\u00a0cohort. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/20855130' target='_blank'>Stead 2010</a>) <ul> <li>In this population of patients with TIA patients, a rapid ED-based outpatient protocol that included early carotid imaging and treatment when appropriate, found that the rate of stroke was independent of ABCD<sup>2</sup> risk stratification. (<a href='http://www.ncbi.nlm.nih.gov/pubmed/20855130' target='_blank'>Stead 2010</a>)</li> </ul> </li> </ul>", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/17258668", "text": "Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, Sidney S. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007 Jan 27;369(9558):283-92."}], "Other References": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/15993230", "text": "Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005 Jul 2-8;366(9479):29-36."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/22700810", "text": "Sanders LM, Srikanth VK, Blacker DJ, Jolley DJ, Cooper KA, Phan TG.Performance of the ABCD2 score for stroke risk post TIA: meta-analysis and probability modeling. Neurology. 2012 Sep 4;79(10):971-80. doi: 10.1212/WNL.0b013e31825f9d02. Epub 2012 Jun 13. PubMed PMID: 22700810."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/20855130", "text": "Stead LG, Suravaram S, Bellolio MF, Enduri S, Rabinstein A, Gilmore RM, Bhagra A, Manivannan V, Decker WW. An assessment of the incremental value of the ABCD2 score in the emergency department evaluation of transient ischemic attack. Ann Emerg Med. 2011 Jan;57(1):46-51. doi: 10.1016/j.annemergmed.2010.07.001. Epub 2010 Sep 19. PubMed PMID: 20855130."}, {"href": "http://www.ncbi.nlm.nih.gov/pubmed/21646462", "text": "Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Symington C, Worster A, \u00c9mond M, Stotts G, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, MacKey A, Verreault S, Wells GA, Stiell IG. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ. 2011 Jul 12;183(10):1137-45. doi: 10.1503/cmaj.101668. Epub 2011 Jun 6. PubMed PMID: 21646462."}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/18688003", "text": "Josephson SA, Sidney S, Pham TN, Bernstein AL, Johnston SC. Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke. 2008 Nov;39(11):3096-8. doi: 10.1161/STROKEAHA.108.514562. Epub 2008 Aug 7."}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Daniel Runde, MD, is currently the assistant residency director and an assistant professor of emergency medicine at the University of Iowa Hospitals and Clinics. He received his medical degree at the University of Iowa Carver College of Medicine and completed residency in emergency medicine at St. Luke\u2019s-Roosevelt Hospital Center in New York. He recently finished his Medical Education Fellowship at the department of emergency medicine at Harbor-UCLA. Dr. Runde is interested in evidence-based medicine with a focus on patient-important clinical outcomes, CT utilization in the emergency department and education and evaluation in medical education. Currently, he is in the process of obtaining a Masters in Medical Education through the Office of Consultation and Research in Medical Education at the University of Iowa Hospitals and Clinics.</p>", "firstName": "Daniel", "img": "https://cdn-web-img.mdcalc.com/people/daniel-runde.jpg", "lastName": "Runde", "name": "Daniel Runde, MD", "target": "daniel-runde", "signedCOI": false, "hasDisclosure": []}]}, "creator": [{"id": 455, "name": "Dr. S. Claiborne Johnston", "qa_en": "<p>We designed the ABCD<sup>2</sup> score to be a simple clinical prediction tool for use in triaging patients presenting with acute TIA. It was based on risk factors identified in cohorts from Northern California and Oxford, England, optimized to predict the 2-day stroke risk. It was initially validated in independent cohorts from those two locations but has now been validated in many other populations. It works pretty well but is far from perfect. Imaging information, such as whether an acute infarction is present, can also be very useful for prognostication and is not incorporated into the score. Although the score has been incorporated into guidelines for hospital admission and more detailed evaluations, it should not be used in place of clinical judgment. For example, a young person with a history of IV drug use and a new murmur presenting with a brief episode of facial tingling might have an ABCD<sup>2</sup> score of 0 yet may be at high short-term risk of stroke.</p>", "approved": false, "priority": 0, "creator_info": {"about_en": "<p>S. Claiborne Johnston, MD, PhD is the Director of the Stroke Service at the University of California, San Francisco, where he is Professor of Neurology and Epidemiology and Director of the Clinical and Translational Science Institute (CTSI). He has published extensively in the prevention and treatment of stroke and transient ischemic attack. Dr. Johnston has been honored with multiple awards including the American Academy of Neurology\u2019s Pessin Prize for Stroke Leadership.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-s-claiborne-johnston.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Johnston+SC%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "toggle", "label_en": "Age \u2265 60 years", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "age_60"}, {"type": "toggle", "label_en": "BP \u2265 140/90 mmHg", "default": 0, "conditionality": "", "show_points": true, "tips_en": "Initial BP. Either SBP \u2265 140 or DBP \u2265 90.", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "bp_140"}, {"type": "radio", "label_en": "Clinical features of the TIA", "default": 2, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Unilateral weakness", "value": 2}, {"label": "Speech disturbance without weakness", "value": 1}, {"label": "Other symptoms", "value": 0}], "name": "tia_features"}, {"type": "radio", "label_en": "Duration of symptoms", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<10 minutes", "value": 0}, {"label": "10-59 minutes", "value": 1}, {"label": "\u2265 60 minutes", "value": 2}], "name": "duration"}, {"type": "toggle", "label_en": "History of diabetes", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "name": "diabetes"}], "md5": "", "cmeVersion": null, "cmeReleaseDate": null, "cmeEndDate": null, "cmeLastReviewed": null, "related_calcs": [{"calcId": 40, "short_title_en": "CHADS<sub>2</sub> Score", "slug": "chads2-score-atrial-fibrillation-stroke-risk"}, {"calcId": 1706, "short_title_en": "THRIVE Score", "slug": "thrive-score-stroke-outcome"}, {"calcId": 1890, "short_title_en": "Modified Rankin Score", "slug": "modified-rankin-scale-neurologic-disability"}]}